Books on the topic 'Prescription pricing. Pharmacy management'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 books for your research on the topic 'Prescription pricing. Pharmacy management.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse books on a wide variety of disciplines and organise your bibliography correctly.
Gondek, Kathleen. Assessment of the impact of pharmacy benefit managers. University of Wisconsin, 1996.
Find full textSteinbacher, Raymond. The Consumer's pharmacy guide: A unique new directory that shows you the most inexpensive, sometimes absolutely free, sources for your prescription needs! Carousel Lion Publications, 2001.
Find full textUlrich, Silvia. Einführung in die pharmazeutische Gesetzeskunde: Österreichisches Apothekenrecht Arzneimittel-, Suchtmittel- und Giftverkehrsrecht Arzneimittelpreisgestaltung. Leykam, 1997.
Find full textDepartment of Human Services. Department of Human Services: Institutional pharmacy costs. Secretary of State, Audits Division, 2002.
Find full textConnecticut. General Assembly. Legislative Program Review and Investigations Committee. Pharmacy benefits and regulation. Connecticut General Assembly, Legislative Program Review and Investigations Committee, 2003.
Find full textPatient care management: A lab workbook for prescription practice. 3rd ed. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013.
Find full textUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. Perspectives on pharmaceutical pricing practices: Hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996. U.S. G.P.O., 1996.
Find full textPatient care management lab: A workbook for prescription practice. 2nd ed. Wolters Kluwer/Lippincott Williams & Wilkins, 2008.
Find full textUnited States. Congress. Senate. Special Committee on Aging. Internet pharmacy and drug importation: Exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005. U.S. G.P.O., 2005.
Find full textMoore, Richard T. Medicaid pharmacy reimbursements: Summary of the oversight hearing of the Joint Committee on Health Care, August 27, 2002, State House, Boston : summary and recommendations. Joint Committee on Health Care], 2002.
Find full textInternational Conference on Pharmacy Economics/Third Party Programs (6th 1985 Montreal, Québec). Proceedings, Pharmacy Economics/Third Party Programs: Le Centre Sheraton, Montreal, Quebec. Pharmacists Planning Service, 1985.
Find full textCalifornia. Legislature. Senate. Committee on Health and Human Services. Health and Human Services Agency pharmacy assistance proposal: An informational hearing of the Senate Health & Human Services Committee. Senate Publications, 2004.
Find full textUnited States. Congress. Senate. A bill to amend title XVIII of the Social Security Act to require prompt payment to pharmacies under part D, to restrict pharmacy co-branding on prescription drug cards issued under such part, and to provide guidelines for Medication Therapy Management Services programs offered by prescription drug plans and MA-PD plans under such part. U.S. G.P.O., 2006.
Find full textSenate, United States Congress. A bill to amend title XVIII of the Social Security Act to require prompt payment to pharmacies under part D, to restrict pharmacy co-branding on prescription drug cards issued under such part, and to provide guidelines for Medication Therapy Management Services programs offered by prescription drug plans and MA-PD plans under such part. U.S. G.P.O., 2007.
Find full textCook, Anna. How health care reform affects pharmaceutical research and development. The Congress of the U.S., Congressional Budget Office, 1994.
Find full textCook, Anna. How health care reform affects pharmaceutical research and development. The Office, 1994.
Find full textReauthorization of the Prescription Drug User Fee Act and FDA reform: Hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997. U.S. G.P.O., 1997.
Find full textUnited States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Subcommittee on Oversight of Government Management, the Federal Workforce, and the District of Columbia. Monitoring CMS' vital signs: Implementation of the Medicare prescription drug benefit : hearing before the Oversight of Government Management, the Federal Workforce, and the District of Columbia Subcommittee of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Ninth Congress, first session, April 5, 2005. U.S. G.P.O., 2006.
Find full textAccountability, Florida Office of Program Policy Analysis and Government. OPPAGA progress report: Changes to Medicaid preferred drug list requirements and competitive bidding pharmacy contracts could save an additional $86.6 million in 2003-04. Florida Office of Program Policy Analysis and Government Accountability, 2003.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Its drug management techniques are similar to those of health maintenance organizations. Bureau of State Audits, 1997.
Find full textAudits, California Bureau of State. Department of Health Services: It needs to better control the pricing of durable medical equipment and medical supplies and more carefully consider its plans to reduce expenditures on these items. Bureau of State Audits, 2002.
Find full textMichele, Butler, ed. Nurse prescribing: Principles and practice. Greenwich Medical Media, 2000.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Its efforts to further reduce prescription drug costs have been hindered by its inability to hire more pharmacists and its lack of aggressiveness in pursuing available cost-saving measures. California State Auditor, Bureau of State Audits, 2003.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: The forensic alcohol program needs to reevaluate its regulatory efforts. The Bureau, 1999.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Use of its port of entry fraud detection programs is no longer justified. Bureau of State Audits, 1999.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Despite shortcomings in the Department's monitoring efforts, limited data suggest its two-plan model does not adversely affect quality of and access to health care. Bureau of State Audits, 1999.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Some of its policies and practices result in higher state costs for the Medical Therapy Program. California State Auditor, Bureau of State Audits, 2004.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: A conflict of interest did not cause the Fresno district's inadequate oversight of skilled nursing facilities. The Bureau, 2000.
Find full textAudits, California Bureau of State. Department of Health Services: Has made little progress in protecting California's children from lead poisoning. Bureau of State Audits, 1988.
Find full textCalifornia. Bureau of State Audits. Department of Health Services: Additional improvements are needed to ensure children are adequately protected from lead poisoning. Bureau of State Audits, 2001.
Find full textOffice, General Accounting. Medicaid: Methods for setting nursing home rates should be improved : report to the Secretary of Health and Human Services. GAO, 1986.
Find full textOffice, General Accounting. Medicaid: The Texas disproportionate share program favors public hospitals. U.S. General Accounting Office, 1993.
Find full textOffice, General Accounting. Medicaid: Waiver program for developmentally disabled is promising but poses some risks : report to Congressional requesters. The Office, 1996.
Find full textOffice, General Accounting. Medicaid: Oregon's managed care program and implications for expansions : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. The Office, 1992.
Find full textOffice, General Accounting. Medicaid: Changes in best price for outpatient drugs purchased by HMOs and hospitals : fact sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives. The Office, 1994.
Find full textOffice, General Accounting. Medicaid: States' efforts to educate and enroll beneficiaries in managed care. The Office, 1996.
Find full textOffice, General Accounting. Medicaid: Tennessee's program broadens coverage but faces uncertain future : report to the Ranking Minority Member, Committee on Commerce, House of Representatives. The Office, 1995.
Find full textOffice, General Accounting. Medicaid: States turn to managed care to improve access and control costs : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. The Office, 1993.
Find full textInstitute, Certified Medical Representatives, ed. The formulary process: Managing the pharmacy benefit. 2nd ed. Certified Medical Representatives Institute, 2002.
Find full textInternet Pharmacy and Drug Importation: Exploring Risks and Benefits: Hearing Before the Special Committee on Aging, United States Senate, One Hundred. Not Avail, 2005.
Find full textPharmacy Reimbursement Rates: Their Adequacy and Impact on Medicaid Beneficiaries (HCFA pub). United States Government Printing, 1994.
Find full textReport to Congress: Pharmacy reimbursement rates : their adequacy and impact on Medicaid beneficiaries. U.S. Dept. of Health and Human Services, Health Care Financing Administration, Office of Research and Demonstrations, 1994.
Find full textPerspectives on pharmaceutical pricing practices: Hearing before the Subcommitte on Oversight and Investigations of the Committee on Commerce, House of Representatives, One hundred Fourth Cogress, second session, September 19, 1996. U.S. G.P.O., 1996.
Find full textBerger, Robert H., Robyn J. Wahl, and M. Paul Chaplin. Formulary management/pharmacy and therapeutics committees. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199360574.003.0028.
Full textR, Berndt Ernst, and National Bureau of Economic Research., eds. Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process. National Bureau of Economic Research, 2004.
Find full textCourtenay, Molly, and Michele Butler. Nurse Prescribing: Principles and Practice. Greenwich Medical Media, 1999.
Find full textMedicaid: Changes in drug prices paid by HMOs and hospitals since enactment of rebate provisions : report to congressional committees. The Office, 1993.
Find full textOffice, General Accounting. Medicaid: Restructuring approaches leave many questions : report to the Chairman, Committee on the Budget, House of Representatives. The Office, 1995.
Find full textOffice, General Accounting. Medicaid: Sustainability of low 1996 spending growth is uncertain : report to the Chairman, Committee on the Budget, U.S. Senate, and to the Chairman, Committee on the Budget, House of Representatives. The Office, 1997.
Find full textOffice, General Accounting. Medicaid: Lessons learned from Arizona's prepaid program : report to the Secretary of Health and Human Services. The Office, 1987.
Find full text